SPC241
Samsetning sem inniheldur dólútegravír eða lyfjafræðilega viðunandi salt þar af (t.d. dólútegravírnatríum) og rilpivírin eða lyfjafræðilega viðunandi salt þar af (t.d. rilpivírínhýdróklóríð)
Status:
HafnaðApplication date:
7.11.2018Application published:
15.11.2018
Medicine name:
JulucaMedicine for children:
No
Timeline
Today
7.11.2018Application
15.11.2018Publication
Marketing license
IS authorization number:
EU/1/18/1282/001-002Date:
29.5.2018
Foreign authorization number:
EU/1/18/1282Date:
16.5.2018
Owner
Name:
VIIV Healthcare CompanyAddress:
251 Little Falls Drive, Wilmington US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113 Reykjavík
Patent
Number:
EP2932970